Side-by-side comparison of AI visibility scores, market position, and capabilities
Increff is an inventory management and merchandising intelligence platform for brands and retailers, raised $10M+ and based in Bengaluru, India.
Increff was founded in 2016 in Bengaluru, India and raised over $10M to build an inventory management and merchandising intelligence platform for fashion, apparel, and lifestyle brands and retailers operating across online and offline channels. The company was founded by former Amazon and McKinsey executives who saw an opportunity to bring data-driven inventory optimization to a market — branded retail in South and Southeast Asia — where most companies still managed inventory through manual processes and gut-feel assortment decisions.\n\nThe Increff platform covers assortment planning, inventory allocation, replenishment optimization, and multi-channel inventory management, with analytics that help merchandising teams understand sell-through rates, size curve performance, and inventory efficiency across their store network and e-commerce channels. The platform's algorithms help brands reduce both excess inventory — a major profitability drain in fashion retail — and stockouts that result in lost sales and markdown pressure.\n\nIncreFF serves fashion, apparel, and lifestyle brands and retailers with significant operations in India and Southeast Asia, and has been expanding its presence in the Middle East and other emerging markets. The company competes against larger WMS and planning vendors like Blue Yonder, as well as regional competitors and in-house solutions, differentiating through its deep fashion industry specialization, cost-effectiveness for mid-sized brands, and focus on markets where most enterprise vendors have thin support and implementation capacity.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.